Jpmorgan Chase & CO Argenx Se Transaction History

Jpmorgan Chase & CO

  • $1.23 Trillion
  • Q4 2024

A detailed history of Jpmorgan Chase & CO transactions in Argenx Se stock. As of the latest transaction made, Jpmorgan Chase & CO holds 5,218 shares of ARGX stock, worth $3.36 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
5,218
Previous 17,670 70.47%
Holding current value
$3.36 Million
Previous $9.58 Million 66.51%
% of portfolio
0.0%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 12, 2025
SELL
$520.52 - $638.33 $6.48 Million - $7.95 Million
-12,452 Reduced 70.47%
5,218 $3.21 Million
Q3 2024

Dec 26, 2024
BUY
$434.22 - $551.9 $4.94 Million - $6.28 Million
11,376 Added 180.74%
17,670 $9.58 Million
Q3 2024

Nov 08, 2024
BUY
$434.22 - $551.9 $4.94 Million - $6.28 Million
11,376 Added 180.74%
17,670 $9.58 Million
Q2 2024

Dec 26, 2024
SELL
$356.01 - $451.55 $4.05 Million - $5.14 Million
-11,376 Reduced 64.38%
6,294 $2.71 Million
Q2 2024

Aug 12, 2024
SELL
$356.01 - $451.55 $2.01 Million - $2.55 Million
-5,648 Reduced 47.3%
6,294 $2.71 Million
Q1 2024

Dec 26, 2024
SELL
$356.95 - $413.29 $2.04 Million - $2.37 Million
-5,728 Reduced 32.42%
11,942 $4.7 Million
Q1 2024

May 10, 2024
SELL
$356.95 - $413.29 $201,319 - $233,095
-564 Reduced 4.51%
11,942 $4.7 Million
Q4 2023

Dec 26, 2024
SELL
$338.91 - $506.01 $1.75 Million - $2.61 Million
-5,164 Reduced 29.22%
12,506 $4.76 Million
Q4 2023

Feb 12, 2024
SELL
$338.91 - $506.01 $3.77 Million - $5.62 Million
-11,111 Reduced 47.05%
12,506 $4.76 Million
Q3 2023

Nov 14, 2023
SELL
$369.35 - $548.43 $21.8 Million - $32.3 Million
-58,913 Reduced 71.38%
23,617 $11.6 Million
Q2 2023

Aug 11, 2023
SELL
$360.14 - $422.58 $4.95 Million - $5.81 Million
-13,753 Reduced 14.28%
82,530 $32.2 Million
Q1 2023

May 11, 2023
BUY
$334.23 - $403.65 $15.3 Million - $18.5 Million
45,712 Added 90.39%
96,283 $35.9 Million
Q4 2022

Feb 13, 2023
BUY
$342.17 - $402.31 $3.51 Million - $4.13 Million
10,259 Added 25.45%
50,571 $19.2 Million
Q3 2022

Nov 14, 2022
BUY
$343.2 - $395.75 $3.45 Million - $3.98 Million
10,056 Added 33.24%
40,312 $14.2 Million
Q2 2022

Aug 11, 2022
BUY
$269.58 - $378.88 $7.73 Million - $10.9 Million
28,679 Added 1818.58%
30,256 $11.5 Million
Q1 2022

May 11, 2022
BUY
$254.45 - $351.06 $236,129 - $325,783
928 Added 142.99%
1,577 $497,000
Q4 2021

Feb 10, 2022
SELL
$272.01 - $353.03 $59,026 - $76,607
-217 Reduced 25.06%
649 $227,000
Q3 2021

Nov 12, 2021
BUY
$295.0 - $350.58 $255,470 - $303,602
866 New
866 $262,000

Others Institutions Holding ARGX

# of Institutions
432
Shares Held
29.2M
Call Options Held
390K
Put Options Held
272K
View Full List

About ARGENX SE

ARGX Quotes by TradingView
  • Ticker ARGX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,323,800
  • Market Cap $35.7B
  • Description
  • argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...
More about ARGX
Track This Portfolio

Track Jpmorgan Chase & CO Portfolio

Follow Jpmorgan Chase & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email